Alumis (ALMS) Shares Outstanding (Diluted Average) (2023 - 2025)

Alumis (ALMS) reported Shares Outstanding (Diluted Average) of $54.3 million for Q1 2025, up 2190.26% year-over-year from $2.4 million in Q1 2024, and up 91.52% quarter-over-quarter from $28.3 million in Q4 2024.

Alumis (ALMS) Shares Outstanding (Diluted Average) (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Shares Outstanding (Diluted Average) data on file, last reported at $54.3 million in Q1 2025.

  • Shares Outstanding (Diluted Average) for Q1 2025 came in at $54.3 million, up 2190.26% year-over-year; the trailing twelve-month figure through Mar 2025 was $54.3 million (up 2190.26% YoY), and the FY2024 annual result was $28.3 million, up 1218.11% from the prior year.
  • Shares Outstanding (Diluted Average) climbed to $54.3 million in Q1 2025 per ALMS's latest filing, from $28.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $54.3 million in Q1 2025 and troughed at $2.1 million in Q3 2023.
  • A 3-year average of $14.2 million and a median of $2.4 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) advanced 15.49% in 2024, then surged 2190.26% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $2.2 million in 2023, then soared by 1218.11% to $28.3 million in 2024, then jumped by 91.52% to $54.3 million in 2025.
  • Business Quant data shows ALMS's Shares Outstanding (Diluted Average) at $54.3 million in Q1 2025, $28.3 million in Q4 2024, and $19.6 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Alumis 1.99 Bn 1.90 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 54.28 Mn
Dec 31, 2024 28.34 Mn
Sep 30, 2024 19.65 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 2.37 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 2.10 Mn
Jun 30, 2023 2.12 Mn